HB 3267

  • Oregon House Bill
  • 2021 Regular Session
  • Introduced in House Feb 23, 2021
  • House
  • Senate
  • Governor

Relating to the price of prescription drugs.

Abstract

Establishes Prescription Drug Affordability Board in Department of Consumer and Business Services to review prices for prescription drug products meeting specified cost criteria. Requires board to establish upper payment limit for drugs that are or are expected to create affordability challenges for health systems and patients in Oregon or health inequities for communities of color. Requires board to establish and assess fees against manufacturers of prescription drug products sold in Oregon for costs of carrying out duties of board. Establishes Prescription Drug Affordability Stakeholder Council to assist board in carrying out its duties.

Bill Sponsors (2)

Votes


No votes to display

Actions


Jun 27, 2021

House

In committee upon adjournment.

Feb 26, 2021

House

Referred to Health Care with subsequent referral to Ways and Means.

Feb 23, 2021

House

First reading. Referred to Speaker's desk.

Bill Text

Bill Text Versions Format
Introduced PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Oregon Legislative Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.